IL-6, the cytokine responsible for initiating systemic inflammation, has been one of the most consistently shown biomarkers of TB-IRIS [14,64,68,69,70,82], alongside its downstream acute phase reactant, CRP [14,18,83]. This evidence concerns the gene CRP and tuberculosis.